Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | H3B-5942 |
Trade Name | |
Synonyms | CS-0047696 |
Drug Descriptions |
H3B-5942 is a selective estrogen receptor covalent antagonist, which antagonizes wild-type and mutant forms of estrogen receptor alpha, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (PMID: 29991605). |
DrugClasses | Hormone - Anti-estrogens 29 |
CAS Registry Number | 2052128-15-9 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Abemaciclib + H3B-5942 | Abemaciclib H3B-5942 | 0 | 0 |
AZD8055 + H3B-5942 | AZD8055 H3B-5942 | 0 | 0 |
Everolimus + H3B-5942 | Everolimus H3B-5942 | 0 | 0 |
H3B-5942 | H3B-5942 | 0 | 0 |
H3B-5942 + Palbociclib | H3B-5942 Palbociclib | 0 | 0 |
H3B-5942 + PF-04691502 | H3B-5942 PF-04691502 | 0 | 0 |
H3B-5942 + PKI-402 | H3B-5942 PKI-402 | 0 | 0 |
H3B-5942 + Ribociclib | H3B-5942 Ribociclib | 0 | 0 |
H3B-5942 + Sirolimus | H3B-5942 Sirolimus | 0 | 0 |
H3B-5942 + Temsirolimus | H3B-5942 Temsirolimus | 0 | 0 |